If I sell an SPF lip balm, does it become an OTC drug in the U.S., and what does that change?

In the U.S., an SPF claim typically makes a lip balm an FDA-regulated OTC sunscreen drug, not just a cosmetic. That impacts your formula constraints, required testing, and labeling (including a Drug Facts panel), and Amazon may ask for supporting documents.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • In the U.S., once your lip balm is marketed with SPF/sunscreen claims, it is generally treated as an OTC sunscreen drug.
  • Practically, this changes what ingredients/levels you can use, what you can claim, and what must appear on the label (often including a Drug Facts box), plus more robust quality documentation.
  • You should plan for OTC-style substantiation: third-party SPF and Broad Spectrum testing (and water-resistance testing only if you claim it), plus stability/compatibility and microbiology.
  • Amazon listings for sunscreen products can be compliance-sensitive, so having COA/SDS, ingredient breakdown, batch records, and test reports ready helps.
  • On the OEM/ODM side, we can support formula customization and sampling (typically 7-10 business days for first lab samples), packaging/VI and artwork setup (stick tubes, squeeze tubes, and custom components), and test coordination with qualified labs.
  • Typical MOQ guidance is 5,000-10,000 pcs per SKU depending on formula/pack, with mass production often 35-45 days after sample and packaging approval.
  • We can also support barcodes, logistics planning, and documentation preparation, but we do not guarantee regulatory acceptance.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).